GREY WOLF ANIMAL HEALTH CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.81 CAD | +12.50% |
|
+3.85% | +9.46% |
| Apr. 11 | Grey Wolf Animal Health Swings to a Q4 Loss Despite Revenue Gain | MT |
| Apr. 11 | Grey Wolf Animal Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | - | 24.21 | 22.96 |
| Enterprise Value (EV) 1 | - | 28.37 | 25.1 |
| P/E ratio | -22.8 x | 5.12 x | 37.7 x |
| Yield | - | - | - |
| Capitalization / Revenue | - | 1.07 x | 0.9 x |
| EV / Revenue | - | 1.25 x | 0.99 x |
| EV / EBITDA | - | 26.1 x | 8.61 x |
| EV / FCF | - | -4,012,125 x | 12,235,110 x |
| FCF Yield | - | -0% | 0% |
| Price to Book | 5.7 x | 1 x | 0.92 x |
| Nbr of stocks (in thousands) | - | 31,032 | 31,032 |
| Reference price 2 | 1.583 | 0.7800 | 0.7400 |
| Announcement Date | 11/2/22 | 4/24/23 | 4/11/24 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales 1 | 7.682 | 13.1 | 22.64 | 25.41 |
| EBITDA 1 | 0.4405 | 1.135 | 1.086 | 2.916 |
| EBIT 1 | -0.2546 | 0.1342 | -0.2819 | 1.658 |
| Operating Margin | -3.31% | 1.03% | -1.25% | 6.53% |
| Earnings before Tax (EBT) 1 | -0.8172 | -1.891 | 1.746 | 1.098 |
| Net income 1 | -0.8964 | -0.9689 | 2.543 | 0.6096 |
| Net margin | -11.67% | -7.4% | 11.24% | 2.4% |
| EPS 2 | -0.0661 | -0.0695 | 0.1522 | 0.0196 |
| Free Cash Flow | - | 3.295 | -7.072 | 2.051 |
| FCF margin | - | 25.16% | -31.24% | 8.07% |
| FCF Conversion (EBITDA) | - | 290.31% | - | 70.35% |
| FCF Conversion (Net income) | - | - | - | 336.54% |
| Dividend per Share | - | - | - | - |
| Announcement Date | 11/2/22 | 11/2/22 | 4/24/23 | 4/11/24 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | - | 19.7 | 4.17 | 2.14 |
| Net Cash position 1 | 0.38 | - | - | - |
| Leverage (Debt/EBITDA) | - | 17.35 x | 3.838 x | 0.7325 x |
| Free Cash Flow | - | 3.3 | -7.07 | 2.05 |
| ROE (net income / shareholders' equity) | - | -28.1% | 18% | 2.47% |
| ROA (Net income/ Total Assets) | - | 0.39% | -0.47% | 2.63% |
| Assets 1 | - | -250.7 | -545.3 | 23.22 |
| Book Value Per Share 2 | 0.2100 | 0.2800 | 0.7800 | 0.8100 |
| Cash Flow per Share 2 | 0.1600 | 0.3000 | 0.2200 | 0.2500 |
| Capex | - | 0.01 | 0.05 | 0.28 |
| Capex / Sales | - | 0.11% | 0.24% | 1.12% |
| Announcement Date | 11/2/22 | 11/2/22 | 4/24/23 | 4/11/24 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +9.46% | 18.47M | |
| -31.10% | 6.99B | |
| +14.81% | 1.88B | |
| -6.91% | 1.72B | |
| -2.71% | 1.47B | |
| -4.29% | 871M | |
| -18.35% | 671M | |
| +13.16% | 392M | |
| -7.38% | 336M | |
| +56.42% | 220M |
- Stock Market
- Equities
- WOLF Stock
- Financials Grey Wolf Animal Health Corp.